1. Home
  2. GLMD vs BBGI Comparison

GLMD vs BBGI Comparison

Compare GLMD & BBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLMD
  • BBGI
  • Stock Information
  • Founded
  • GLMD 2000
  • BBGI 1961
  • Country
  • GLMD Israel
  • BBGI United States
  • Employees
  • GLMD N/A
  • BBGI N/A
  • Industry
  • GLMD Biotechnology: Pharmaceutical Preparations
  • BBGI Broadcasting
  • Sector
  • GLMD Health Care
  • BBGI Consumer Discretionary
  • Exchange
  • GLMD Nasdaq
  • BBGI Nasdaq
  • Market Cap
  • GLMD 7.9M
  • BBGI 7.6M
  • IPO Year
  • GLMD 2014
  • BBGI 2000
  • Fundamental
  • Price
  • GLMD $1.49
  • BBGI $4.55
  • Analyst Decision
  • GLMD Hold
  • BBGI
  • Analyst Count
  • GLMD 1
  • BBGI 0
  • Target Price
  • GLMD N/A
  • BBGI N/A
  • AVG Volume (30 Days)
  • GLMD 164.0K
  • BBGI 6.5K
  • Earning Date
  • GLMD 09-02-2025
  • BBGI 08-12-2025
  • Dividend Yield
  • GLMD N/A
  • BBGI N/A
  • EPS Growth
  • GLMD N/A
  • BBGI N/A
  • EPS
  • GLMD N/A
  • BBGI N/A
  • Revenue
  • GLMD N/A
  • BBGI $227,387,784.00
  • Revenue This Year
  • GLMD N/A
  • BBGI $5.02
  • Revenue Next Year
  • GLMD N/A
  • BBGI N/A
  • P/E Ratio
  • GLMD N/A
  • BBGI N/A
  • Revenue Growth
  • GLMD N/A
  • BBGI N/A
  • 52 Week Low
  • GLMD $1.15
  • BBGI $3.67
  • 52 Week High
  • GLMD $23.80
  • BBGI $14.95
  • Technical
  • Relative Strength Index (RSI)
  • GLMD 44.36
  • BBGI 54.44
  • Support Level
  • GLMD $1.35
  • BBGI $4.35
  • Resistance Level
  • GLMD $1.59
  • BBGI $4.88
  • Average True Range (ATR)
  • GLMD 0.11
  • BBGI 0.20
  • MACD
  • GLMD 0.00
  • BBGI 0.02
  • Stochastic Oscillator
  • GLMD 44.56
  • BBGI 58.13

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

About BBGI Beasley Broadcast Group Inc.

Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.

Share on Social Networks: